1. Home
  2. IKT
  3. IKT News

Latest Inhibikase Therapeutics Inc. (IKT) News on November 24, 2024

Inhibikase Therapeutics Announces Closing of up to $275 Million Financing and Advancement of IkT-001Pro into a Late Stage Clinical Trial in Pulmonary Arterial Hypertension

GlobeNewswire

a month ago

Inhibikase Therapeutics Announces Closing of up to $275 Million Financing and Advancement of IkT-001Pro into a Late Stage Clinical Trial in Pulmonary Arterial Hypertension

Thomson Reuters StreetEvents

8 months ago

Q4 2023 Inhibikase Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

a year ago

Q3 2023 Mammoth Energy Services Inc Earnings Call

Share on Social Networks: